India

Prices Of Diabetes, Heart & Kidney Drugs Could Be Slashed

By
OB Bureau

New Delhi: The government is planning to bring down the prices of critical drugs by fixing trade margins, according to News18.com.

Trade margins are the difference between the price to trade for manufacturers and the price to patients as the maximum retail price (MRP).

“The efforts are to reduce prices of drugs used for the treatment of diabetic, cardiovascular diseases, and chronic kidney diseases,” the report said quoting a top official in the ministry of health and family welfare.

The trade margin will be rationalised in a phased manner as it enables better execution and gives time to the industry to accommodate changes, the source said while hinting that the move is expected to be announced soon.

“For instance, we first slashed the margins in the anti-cancer category. Similarly, this time, we will announce the slashing of the trade margins of a particular category of drugs such as anti-diabetic or for kidney diseases,” said the source.

Drug price watchdog National Pharmaceutical Pricing Authority (NPPA) has been working on the plan for the past several months.

In 2018-19, the NPPA had put a cap on trade margins of 42 select non-scheduled anti-cancer medicines. Union health minister Mansukh Mandaviya had said in the Lok Sabha that the move resulted in the reduction of up to 90% of the MRP of 526 brands of these medicines.

This time, the source said, NPPA has conducted a study and the rationalisation will be based on the inputs from the same.

According to the study on TMR analysis conducted by NPPA, a trader’s margin moves higher with the price of a tablet.

It found that, for instance, if a tablet is priced up to Rs 2, in the majority of the brands, the margin is up to 50%; whereas if its cost is between Rs 15 and Rs 25, the margin is less than 40%.

At least 2.97% of the medicines in the Rs 50-100 per tablet category have trade margins between 50% and 100%, 1.25% in the category have margins between 100% and 200%, and 2.41% have margins between 200% and 500%.

As per NPPA’s presentation, in the case of medicines priced above Rs 100 per tablet, considered the costliest category, 8% have margins around 200% to 500%, 2.7% have margins around 500-1000%, and 1.48% have more than 1000% margins.

OB Bureau

Recent Posts

IPL Auction: KKR Break Bank For Venkatesh On Lucrative Day For Indian Players; Check Top Buys

Mumbai: The first day of the IPL mega player auction at Jeddah threw up several…

November 24, 2024

Odisha Govt Hands Over Case Of Attack On Dharmasala MLA To Crime Branch

Bhubaneswar: The Odisha government has handed over the investigation into the attack on Dhramasala MLA…

November 24, 2024

Commissionerate Police Issues Traffic Advisory During Winter Session Of Odisha Assembly; Details Here

Bhubaneswar: The Commissionerate of Police on Sunday issued an advisory for movement of vehicular traffic…

November 24, 2024

Elon Musk Proposal: Fire US Federal Employees Who Want To Work From Home

New York: Now that President-elect Donald Trump has tasked Elon Musk with the responsibility of co-heading…

November 24, 2024

Odisha Govt Warns Of Stern Action For Renting Out Its Quarters

Bhubaneswar: The Odisha government has warned its employees of stern action for sub-letting their allotted…

November 24, 2024

AR Rahman Best Man In The World, Certifies Saira Banu; Then Why Their Separation?

Mumbai: There has been a lot of talk over AR Rahman and his wife Saira…

November 24, 2024

Process On To Form NODC In 2-3 Months, Says Odisha CM Mohan Majhi

Sundargarh: The North Odisha Development Council (NODC) would be formed in 2-3 months, said Chief…

November 24, 2024

Odisha DGP Reviews Security Arrangements For President’s Visit To Puri

Puri: Director General of Police (DGP) YB Khurania on Sunday reviewed the security arrangements for…

November 24, 2024